• Guidance Document: Tamper-resistance Formulations of Opioid Drug Products
• Submitting risk management plans draft guidance document: Opioid products
• Problematic Opioid Use (fact sheet)
• Opioid Medicines – Part A: Opioid Warning Sticker
• Restricting the Marketing and Advertising of Opioids